MARCH 27
  • Days

  • :
  • Hrs

  • :
  • Min

  • :
  • Sec

ePoster Gallery

P390: The Effect of Rurality Status on Radiation Outcomes for Pancreatic Adenocarcinoma. A Retrospective Study of the Surveillance, Epidemiology, and End Results Database
Saad Khan
P391: The Experience and Perception of Uncertainty in Patients with Pancreatic Cancer Undergoing Neoadjuvant Therapy
Orly Farber MD
Brigham and Women's Hospital
P392: The Oncopig cancer model, an innovative large animal platform for evaluating novel endoscopic and surgical applications
Ajay Maker MD
University of California San Francisco
P393: The Role of Primary and Liver Resection for Liver-Metastatic Gastro-Entero-Pancreatic Neuroendocrine Tumors: Grade Matters
Thomas Sutton MD MCR
Cedars-Sinai Medical Center
P394: The T Cell Receptor T Cell (TCR-T) Index: The potential of targeting gastrointestinal cancer with off-the-shelf TCR-T cells
Aaron Dinerman
NCI
P395: The practice of pancreatic neck margin testing and outcomes after pancreatoduodenectomy for pancreatic cancer
Kimberly Woo MD
Cleveland Clinic
P396: Well-moderately differentiated 1-2cm non-functional pancreatic neuroendocrine tumors: what factors impact management?
Omid Salehi
Roger Williams Medical Center
P397: Who Are the Long-Term Survivors in Pancreatic Ductal Adenocarcinoma (PDAC)?: An Analysis of the National Cancer Database
Julien Hohenleitner MD
Northwell Health
P398: A 10-Year review of Merkel Cell Carcinoma evaluating surgical margin width and other predictors of disease recurrence
Jack Sample MD
Mayo Clinic
P399: An Exploration of Rural Access Disparities for Patients with Stage III-IV Melanoma
Brailyn Weber MS4
University of North Dakota School of Medicine
P400: Assessing the 10% Rule in Sentinel Lymph Node Biopsy in Merkel Cell Cancer
Neha Malik MD, MS
MD Anderson Cancer Center
P401: CD45RO-Based Digital Spatial Proteomic Signatures Predict Immunotherapy Response in Melanoma
David su MD
Yale New Haven Hospital
P403: Defining Real-World Treatment Failure of First-line Immunotherapy in Locally Advanced and Metastatic Melanoma
Walter Donica
University of Louisville
P404: Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma of the Trunk and Upper Extremities
Crystal Taylor
University of Michigan
P405: Factors Influencing Sentinel Lymph Node Biopsy Utilization in Non-Ulcerated Melanomas 1mm or Greater
Mackenzie Mayhew MD
University of Virginia
P406: Gender stratified by age does not impact survival in patients with advanced melanoma receiving immunotherapy
Hilary Keller MD
Providence Saint John's Cancer Institute
P407: Impact of Time to Surgery on Outcomes Following Surgery for Melanoma
Rainya Heath
Memorial Healthcare System
P408: Is Patient Age Associated with Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma?
Neha Shafique MD
Hospital of University of Pennsylvania